StockData
IBONYSEPharmaceutical PreparationsFiscal year ends December 31

IMPACT BIOMEDICAL INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026

Market cap
$329.93M
P/E (TTM)
–
Dividend yield
–

IMPACT BIOMEDICAL INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Impact Biomedical does not break out revenue by segment, region or product in the tagged data of its filings for this period type.